Brief: Nova Eye Medical Sees Sales Growth Of At Least 15% Forecast For First Four Months Of Fy23
Aug 26 (Reuters) - Nova Eye Medical Ltd EYE.AX :
* PROJECTED SALES GROWTH OF AT LEAST 15% FORECAST FOR FIRST
FOUR
MONTHS OF FY23
* SALES FOR FOUR MONTHS TO 31 OCTOBER 2022 ARE EXPECTED TO
BE MORE
THAN US$3.4M
Source text for Eikon: ID:nASX8JDxQD
Further company coverage: EYE.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Nova Eye Medical
See all newsAustralia's Nova Eye Medical jumps on upbeat FY27 earnings guidance
Brief: Nova Eye Medical Reports FY26 Sales Of $23.7 Million
Australia's Nova Eye Medical soars on FY26 sales forecast upgrade
Brief: Nova Eye Medical Upgrades Fy26 Sales Guidance (Ex-China) To $22–23 Million
Australia's Nova Eye Medical rises on EU approval for glaucoma treatment